GE Healthcare has partnered with RadNet, a network of outpatient diagnostic imaging centers, to pilot its Best Pathways initiative, a breast cancer detection model.

BOSTONWith 50,000 pages of content on the National Cancer Institute's cancer.gov website, shaping the organization's mobile strategy was no easy task. Jonathan Cho, chief of communications technology for the National Cancer Institute, discussed the process during the Medicine 2.0 Congress.

The FDA has approved the somo-v Automated Breast Ultrasound System for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.

Beth Israel Deaconess Medical Center in Boston has purchased four Carestream DRX-Revolution mobile x-ray systems for multiple intensive care units serving trauma, cardiac, surgical and other critical care patients.

The FDA has granted 510(k) clearance for the thoracic-length HeliFX aortic securement system, an updated system to the one cleared in November 2011 to treat abdominal aortic aneurysms. The new system has a longer delivery device with additional tip configurations to bring the helical EndoAnchor technology to the treatment of thoracic aortic aneurysms (TAA).

Massachusetts Eye and Ear Infirmary and its affiliated physician group, Massachusetts Eye and Ear Associates, will pay $1.5 million to settle a HIPAA security-rule violation case.

Breath testing could be used to discriminate between benign and malignant pulmonary nodules, according to a pilot study published in the October issue of the Journal of Thoracic Oncology.

Supplements of the antioxidant Tempol in the diet of mice were able to safely reduce body weight, reduce or delay onset of cancer and extend survival, according to a study published in the Sept. 15 issue of Cancer Research.